Medicaid insurers claw back some losses amid budget cuts threat
Seeking Alpha News (Thu, 27-Feb 11:04 AM ET)
CVS Pharmacy introduces enhanced flu testing and treatment offerings
PRNewswire (Thu, 27-Feb 9:45 AM ET)
Medicaid-focused insurers down as major budget cuts to program seem likely
Seeking Alpha News (Wed, 26-Feb 1:34 PM ET)
CVS Health ordered to turn over documents related to FTC probe
Seeking Alpha News (Wed, 26-Feb 8:50 AM ET)
President Trump signs executive order for healthcare price transparency
Seeking Alpha News (Wed, 26-Feb 6:54 AM ET)
TipRanks (Tue, 25-Feb 12:50 AM ET)
Notable healthcare headlines for the week: UnitedHealth, Moderna, Sanofi in focus
Seeking Alpha News (Sun, 23-Feb 8:35 AM ET)
Thermo Fisher Scientific Elects New Director to Board
Business Wire (Wed, 19-Feb 4:00 PM ET)
Ed DeVaney named President of CVS Caremark
PRNewswire (Mon, 17-Feb 9:30 AM ET)
CVS HEALTH CORPORATION REPORTS FOURTH QUARTER AND FULL-YEAR 2024 RESULTS
PRNewswire (Wed, 12-Feb 6:30 AM ET)
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the us. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 26 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all its existing business lines.
CVS Health trades on the NYSE stock market under the symbol CVS.
As of February 28, 2025, CVS stock price climbed to $64.61 with 3,201,654 million shares trading.
CVS has a beta of 0.68, meaning it tends to be less sensitive to market movements. CVS has a correlation of 0.04 to the broad based SPY ETF.
CVS has a market cap of $81.46 billion. This is considered a Large Cap stock.
Last quarter CVS Health reported $98 billion in Revenue and $1.19 earnings per share. This beat revenue expectation by $530 million and exceeded earnings estimates by $.26.
In the last 3 years, CVS traded as high as $109.69 and as low as $43.56.
The top ETF exchange traded funds that CVS belongs to (by Net Assets): VTI, VOO, SPY, IVV, VTV.
CVS has underperformed the market in the last year with a return of -11.8%, while SPY returned +17.1%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in CVS shares. However, CVS has outperformed the market in the last 3 month and 2 week periods, returning +8.9% and -2.7%, while SPY returned -1.7% and -3.8%, respectively. This indicates CVS has been having a stronger performance recently.
CVS support price is $63.26 and resistance is $65.70 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CVS shares will trade within this expected range on the day.